Skip to main content
Fig. 3 | Critical Care

Fig. 3

From: The soluble mannose receptor (sMR/sCD206) in critically ill patients with invasive fungal infections, bacterial infections or non-infectious inflammation: a secondary analysis of the EPaNIC RCT

Fig. 3

Receiver operating characteristic curves of sMR concentration to predict an invasive fungal or bacterial infection. a. aROC for sMR to differentiate invasive fungal infection from no invasive fungal infection. The optimal cut-off for sMR is 1.04 mg/L with a corresponding sensitivity of 40.2% and specificity of 82.2%. b. aROC for sMR to differentiate infection from no infection. The optimal cut-off for sMR is 0.71 mg/L with a corresponding sensitivity of 64.4% and specificity of 68.8%. c. aROC for sMR to differentiate an invasive fungal infection from a bacterial infection. The optimal cut-off is 1.04 mg/L with a corresponding sensitivity of 40.3% and specificity of 76.3%. aROC: area under the receiver-operating-curve

Back to article page

Critical Care

ISSN: 1364-8535